|
Quinidine
|
D03.132.206.636 |
|
|
Severe Acute Respiratory Syndrome
|
C08.730.730 |
|
|
Hyperlipidemia, Familial Combined
|
C18.452.648.398.450 |
|
|
Interleukin-23
|
D23.529.374.465.550 |
|
|
Blood Gas Monitoring, Transcutaneous
|
E01.370.386.700.100.600.100 |
|
|
Oximetry
|
E01.370.386.700.100.600 |
|
|
Cohort Studies
|
E05.318.372.500.750 |
|
|
Cathepsin A
|
D08.811.277.656.224.062 |
|
|
Moraxella
|
B03.660.250.530.525 |
|
|
Moraxellaceae
|
B03.660.250.530 |
|
|
Iridescence
|
D000068897 |
[The changing of the color of an object due to variations in the angle of illumination or observation.
] |
|
Raltegravir Potassium
|
D000068898 |
[A pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.
] |
|
Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination
|
D000068899 |
[A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.
] |
|
Kanamycin Resistance
|
G06.099.225.875 |
|
|
Validation Studies as Topic
|
N05.715.360.335.500 |
|
|
Chromosomes, Plant
|
G05.360.162.560 |
|
|
Mental Healing
|
E02.190.901.500 |
|
|
Iodoquinol
|
D03.633.100.810.350.625.420 |
|
|
Oxyquinoline
|
D03.633.100.810.350.625 |
|
|
Cartilage Diseases
|
C17.300.182 |
|
